USA flag logo/image

An Official Website of the United States Government

MONOCLONAL ANTIBODIES TO APOLIPOPROTEIN A-1

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
1523
Program Year/Program:
1986 / SBIR
Agency Tracking Number:
1523
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Hybridoma Sciences Inc.
4761 High Howell Road Suite D Atlanta, GA 30084
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 2
Fiscal Year: 1986
Title: MONOCLONAL ANTIBODIES TO APOLIPOPROTEIN A-1
Agency: HHS
Contract: N/A
Award Amount: $319,000.00
 

Abstract:

LIPOPROTEINS ARE HIGH MOLECULAR WEIGHT WATER-SOLUBLE COMPLEXES COMPOSED OF LIPID AND ONE OR MORE SPECIFIC PROTEINS. THEY ARE GROUPED ACCORDING TO THEIR DENSITY AS DETERMINED BY ULTRACENTRIFUGATION. PLASMA LOW DENSITY LIPOPROTEINS (LDL) CONTAIN APPROXIMATELY 75% LIPID AND 25% PROTEIN AND FUNCTION AS A MAJOR CARRIER OF CHOLESTEROL. APOLIPOPROTEIN B IS THE STRUCTURAL PROTEIN MOIETY OF LDL (1). THE MEASUREMENT OF ELEVATED LEVELS OF APOLIPOPROTEIN B HAS BEEN REPORTED TO BE A MARKER OF CORONARY ARTERY DISEASE (2). IN ADDITION THE MEASUREMENT OF REDUCED LEVELS OF HIGH-DENSITY LIPOPROTEIN (HDL) CHOLESTEROL (3) AND APOLIPOPROTEIN A-1 HAVE ALSO BEEN REPORTED TO BE A MARKER. HDL CONTAINS APPROXIMATELY 50% APOLIPOPROTEIN WITH 32% OF THE LIPID COMPONENT BEING CHOLESTEROL AND 65% OF THE APOLIPOPROTEIN BEING A-1(5). WE HAVE PREVIOUSLY DEVELOPED MONOCLONAL ANTIBODIES WITH SPECIFICITY FOR APOLIPOPROTEIN B FROM HUMAN PLASMA LDL (6). BECAUSE OF THE ROLE THAT LIPOPROTEINS PLAY IN THE PATHOGENESIS OF ATHEROSCLEROSIS THEIR QUANTITATION IS IMPORTANT NOT ONLY FOR METABOLIC STUDIES BUT FOR THE CHARACTERIZATION OF DYSLIPOPROTEINEMIAS. THE SPECIFIC AIMS OF THIS PROJECT ARE TO DEVELOP AND CHARACTERIZE MONOCLONAL ANTIBODIES TO HUMAN APOLIPOPROTEIN A-1 (PHASE 1) AND TO USE THESE ANTIBODIES AS REFERENCE STANDARDS FOR THE ISOLATION OR IDENTIFICATION OF APOLIPOPROTEIN A-1 AND AS SENSITIVE INDICATORS OF CORONARY ARTERY DISEASE (PHASE II).

Principal Investigator:

Paul J. Price
Director
0

Business Contact:

Small Business Information at Submission:

Hybridoma Sciences Inc.
4761 High Howell Road Suite D Atlanta, GA 30084

EIN/Tax ID:
DUNS: N/A
Number of Employees:
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No